Huang, M.; Tallon, C.; Zhu, X.; Huizar, K.D.J.; Picciolini, S.; Thomas, A.G.; Tenora, L.; Liyanage, W.; Rodà, F.; Gualerzi, A.;
et al. Microglial-Targeted nSMase2 Inhibitor Fails to Reduce Tau Propagation in PS19 Mice. Pharmaceutics 2023, 15, 2364.
https://doi.org/10.3390/pharmaceutics15092364
AMA Style
Huang M, Tallon C, Zhu X, Huizar KDJ, Picciolini S, Thomas AG, Tenora L, Liyanage W, Rodà F, Gualerzi A,
et al. Microglial-Targeted nSMase2 Inhibitor Fails to Reduce Tau Propagation in PS19 Mice. Pharmaceutics. 2023; 15(9):2364.
https://doi.org/10.3390/pharmaceutics15092364
Chicago/Turabian Style
Huang, Meixiang, Carolyn Tallon, Xiaolei Zhu, Kaitlyn D. J. Huizar, Silvia Picciolini, Ajit G. Thomas, Lukas Tenora, Wathsala Liyanage, Francesca Rodà, Alice Gualerzi,
and et al. 2023. "Microglial-Targeted nSMase2 Inhibitor Fails to Reduce Tau Propagation in PS19 Mice" Pharmaceutics 15, no. 9: 2364.
https://doi.org/10.3390/pharmaceutics15092364
APA Style
Huang, M., Tallon, C., Zhu, X., Huizar, K. D. J., Picciolini, S., Thomas, A. G., Tenora, L., Liyanage, W., Rodà, F., Gualerzi, A., Kannan, R. M., Bedoni, M., Rais, R., & Slusher, B. S.
(2023). Microglial-Targeted nSMase2 Inhibitor Fails to Reduce Tau Propagation in PS19 Mice. Pharmaceutics, 15(9), 2364.
https://doi.org/10.3390/pharmaceutics15092364
